Schedule 13D ownership disclosure

N/A

Common Stock, par value $0.001 per share · CUSIP: 14179K101

Event date: 2025-02-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621

    Shares: 2,729,288.00 · Class: 5.9%

  • KEVIN TANGReported CIK 0001178579

    Shares: 2,729,288.00 · Class: 5.9%

  • TANG CAPITAL PARTNERS, LPReported CIK 0001191935

    Shares: 1,534,946.00 · Class: 3.3%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 1,194,342.00 · Class: 2.6%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0%

  • CONCENTRA BIOSCIENCES, LLCReported CIK 0001970065

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-003297
Form type
SCHEDULE 13D
Filer
CARGO Therapeutics, Inc.
CIK
CIK 1966494
Filed
Feb 21, 2025
Reporting period
Feb 13, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub